Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00005088 · ClinicalTrials.gov registry record · Phase 2
Radiation Therapy and Cisplatin in Treating Patients With Advanced Head and Neck Cancer
A Phase 2 study, sponsored by Radiation Therapy Oncology Group.
- Completed
- Registry status
- Phase 2
- Development phase
NCT00005088 is a Phase 2 study that has completed, run by Radiation Therapy Oncology Group.
The verdict
NCT00005088, a Phase 2 study, has completed, sponsored by Radiation Therapy Oncology Group.
- COMPLETED
- Registry status
- Phase 2
- Development phase
Study Summary
RATIONALE: Radiation therapy uses high-energy x-rays to damage tumor cells. Drugs used in chemotherapy use different ways to stop tumor cells from dividing so they stop growing or die. Combining chemotherapy with radiation therapy may kill more tumor cells. PURPOSE: Phase II trial to study the effectiveness of radiation therapy and cisplatin in treating patients who have advanced head and neck cancer.
Interventions
- DRUG cisplatin
- RADIATION radiation therapy
Trial Details
| Field | Value |
|---|---|
| Start Date | 2000-04 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00005088
The ClinicalTrials.gov registry entry for NCT00005088 describes a study currently listed as completed, categorized as Phase 2. An enrollment target was not published in the registry record, which is common for early-stage or observational entries. The listed sponsor is Radiation Therapy Oncology Group, which has 144 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which cisplatin is the first listed.
NCT00005088 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00005088 about?
NCT00005088 is a clinical study titled "Radiation Therapy and Cisplatin in Treating Patients With Advanced Head and Neck Cancer". RATIONALE: Radiation therapy uses high-energy x-rays to damage tumor cells. Drugs used in chemotherapy use different ways to stop tumor cells from dividing so they stop growing or die. Combining chemotherapy with radiation therapy may kill more tumor cells. PURPOSE: Phase II trial to study the effe...
What is the current status of trial NCT00005088?
This trial is currently completed. It is a Phase 2 study. The study started on 2000-04.
What interventions are being tested in trial NCT00005088?
The interventions under investigation include: cisplatin (DRUG), radiation therapy (RADIATION).
Who is sponsoring clinical trial NCT00005088?
This trial is sponsored by Radiation Therapy Oncology Group, which has 144 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.